Umezawa Y - Search Results

1

Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.

Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S. Matsubara T, et al. Among authors: umezawa y. Scand J Rheumatol. 1997;26(4):314-7. doi: 10.3109/03009749709105322. Scand J Rheumatol. 1997. PMID: 9310113

2

Increased expression of Fc epsilon R2/CD23 on peripheral blood B lymphocytes and serum IgE levels in Kawasaki disease.

Furukawa S, Matsubara T, Motohashi T, Sasai K, Nakachi S, Umezawa Y, Yabuta K. Furukawa S, et al. Among authors: umezawa y. Int Arch Allergy Appl Immunol. 1991;95(1):7-12. doi: 10.1159/000235446. Int Arch Allergy Appl Immunol. 1991. PMID: 1833342

3

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.

Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K. Furukawa S, et al. Among authors: umezawa y. J Pediatr. 1994 May;124(5 Pt 1):721-5. doi: 10.1016/s0022-3476(05)81361-7. J Pediatr. 1994. PMID: 8176558

4

Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease.

Furukawa S, Matsubara T, Umezawa Y, Motohashi T, Ino T, Yabuta K. Furukawa S, et al. Among authors: umezawa y. Eur J Pediatr. 1994 Sep;153(9):663-7. doi: 10.1007/BF02190688. Eur J Pediatr. 1994. PMID: 7957426 Clinical Trial.

5

Activation of peripheral blood monocytes and macrophages in Kawasaki disease: ultrastructural and immunocytochemical investigation.

Koga M, Ishihara T, Takahashi M, Umezawa Y, Furukawa S. Koga M, et al. Among authors: umezawa y. Pathol Int. 1998 Jul;48(7):512-7. doi: 10.1111/j.1440-1827.1998.tb03942.x. Pathol Int. 1998. PMID: 9701013

6

Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets.

Furukawa S, Matsubara T, Tsuji K, Motohashi T, Watanabe T, Umezawa Y, Yabuta K. Furukawa S, et al. Among authors: umezawa y. J Infect Dis. 1991 Feb;163(2):416-7. doi: 10.1093/infdis/163.2.416. J Infect Dis. 1991. PMID: 1824854 No abstract available.

7

Determination of IgG subclasses of immunoglobulin preparations for intravenous injection and the problems involved.

Tokano Y, Umezawa Y, Okumura K. Tokano Y, et al. Among authors: umezawa y. Immunol Res. 1994;13(1):56-60. doi: 10.1007/BF02918225. Immunol Res. 1994. PMID: 7897263

8

Relationship between lymphocyte cyclosporin sensitivity and clinical progress of psoriasis.

Umezawa Y, Oh-i T, Koga M. Umezawa Y, et al. J Dermatol Sci. 2001 Jun;26(2):94-9. doi: 10.1016/s0923-1811(00)00166-3. J Dermatol Sci. 2001. PMID: 11378324

9

Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.

Hirano T, Oka K, Takeuchi H, Kozaki K, Matsuno N, Nagao T, Kozaki M, Ichikawa M, Yoshida M, Umezawa Y, Hirata M, Oh-i T, Koga M. Hirano T, et al. Among authors: umezawa y. Clin Pharmacol Ther. 1997 Dec;62(6):652-64. doi: 10.1016/S0009-9236(97)90085-0. Clin Pharmacol Ther. 1997. PMID: 9433394

10

Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine efficacy in psoriasis.

Hirano T, Oka K, Umezawa Y, Hirata M, Oh-i T, Koga M. Hirano T, et al. Among authors: umezawa y. Clin Pharmacol Ther. 1998 Apr;63(4):465-70. doi: 10.1016/S0009-9236(98)90042-X. Clin Pharmacol Ther. 1998. PMID: 9585801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

390 results

Search Page

Filters